Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 689018, 14 pages
http://dx.doi.org/10.1155/2010/689018
Review Article

Progress on Antiangiogenic Therapy for Patients with Malignant Glioma

1Brain Tumor Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
2Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
3Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA

Received 21 November 2009; Revised 25 January 2010; Accepted 11 February 2010

Academic Editor: Arkadiusz Dudek

Copyright © 2010 Manmeet S. Ahluwalia and Candece L. Gladson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [37 citations]

The following is the list of published articles that have cited the current article.

  • Karina Christensen, Henrik Daa Schroder, and Bjarne Winther Kristensen, “CD133(+) niches and single cells in glioblastoma have different phenotypes,” Journal of Neuro-Oncology, vol. 104, no. 1, pp. 129–143, 2011. View at Publisher · View at Google Scholar
  • Marlies Wagner, Reinhold Nafe, Alina Jurcoane, Ulrich Pilatus, Kea Franz, Johannes Rieger, Joachim P. Steinbach, and Elke Hattingen, “Heterogeneity in malignant gliomas: a magnetic resonance analysis of spatial distribution of metabolite changes and regional blood volume,” Journal Of Neuro-Oncology, vol. 103, no. 3, pp. 663–672, 2011. View at Publisher · View at Google Scholar
  • Manmeet S Ahluwalia, and Patrick Y Wen, “Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging and future directions,” Expert Review of Anticancer Therapy, vol. 11, no. 5, pp. 653–656, 2011. View at Publisher · View at Google Scholar
  • M. Kelly Nicholas, Rimas V. Lukas, Steven Chmura, Bakhtihar Yamini, Maciej Lesniak, and Peter Pytel, “Molecular Heterogeneity in Glioblastoma: Therapeutic Opportunities and Challenges,” Seminars in Oncology, vol. 38, no. 2, pp. 243–253, 2011. View at Publisher · View at Google Scholar
  • Manmeet S Ahluwalia, “2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies,” Expert Review of Anticancer Therapy, vol. 11, no. 2, pp. 161–163, 2011. View at Publisher · View at Google Scholar
  • Manmeet S Ahluwalia, Mital Patel, and David M Peereboom, “Role of tyrosine kinase inhibitors in the management of high-grade gliomas,” Expert Review of Anticancer Therapy, vol. 11, no. 11, pp. 1739–1748, 2011. View at Publisher · View at Google Scholar
  • Mersiha Hadziahmetovic, Katsuyuki Shirai, and Arnab Chakravarti, “Recent advancements in multimodality treatment of gliomas,” Future Oncology, vol. 7, no. 10, pp. 1169–1183, 2011. View at Publisher · View at Google Scholar
  • Tobias Birnbaum, Jenna Hildebrandt, Georg Nuebling, Petra Sostak, and Andreas Straube, “Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro,” Journal Of Neuro-Oncology, vol. 105, no. 1, pp. 57–65, 2011. View at Publisher · View at Google Scholar
  • Albert Lai, Anh Tran, Phioanh L. Nghiemphu, Whitney B. Pope, Orestes E. Solis, Michael Selch, Emese Filka, William H. Yong, Paul S. Mischel, Linda M. Liau, Surasak Phuphanich, Keith Black, Scott Peak, Richard M. Green, Cynthia E. Spier, Tatjana Kolevska, Jonathan Polikoff, Louis Fehrenbacher, Robert Elashoff, and Timothy Cloughesy, “Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme,” Journal Of Clinical Oncology, vol. 29, no. 2, pp. 142–148, 2011. View at Publisher · View at Google Scholar
  • Eva-Maria Galan-Moya, Sherri S. Smith, Julie Dwyer, Jagoda K. Hebda, Armelle Le Guelte, Sandy Azzi, Nicolas Bidere, and Julie Gavard, “Glioblastoma Cell-Secreted Interleukin-8 Induces Brain Endothelial Cell Permeability via CXCR2,” PLoS ONE, vol. 7, no. 9, 2012. View at Publisher · View at Google Scholar
  • Mital Patel, Michael A Vogelbaum, Gene H Barnett, Rakesh Jalali, and Manmeet S Ahluwalia, “Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions,” Expert Opinion on Investigational Drugs, vol. 21, no. 9, pp. 1247–1266, 2012. View at Publisher · View at Google Scholar
  • Sanjay K. Singh, Alenoush Vartanian, Kelly Burrell, and Gelareh Zadeh, “A microRNA link to glioblastoma heterogeneity,” Cancers, vol. 4, no. 3, pp. 846–872, 2012. View at Publisher · View at Google Scholar
  • Elena Victoria Rosca, Bachchu Lal, Jacob E. Koskimaki, Aleksander S. Popel, and John Laterra, “Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth,” Anti-Cancer Drugs, vol. 23, no. 7, pp. 706–712, 2012. View at Publisher · View at Google Scholar
  • Ali S Arbab, “Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma.,” Histology and histopathology, vol. 27, no. 5, pp. 549–57, 2012. View at Publisher · View at Google Scholar
  • Ping Huang, M. R. Sandhya Rani, Manmeet S. Ahluwalia, Eunnyung Bae, Richard A. Prayson, Robert J. Weil, Amy S. Nowacki, Hirad Hedayat, Andrew E. Sloan, Justin D. Lathia, Jeremy N. Rich, Russell Tibbs, and Candece L. Gladson, “Endothelial Expression of TNF Receptor-1 Generates a Proapoptotic Signal Inhibited by Integrin alpha 6 beta 1 in Glioblastoma,” Cancer Research, vol. 72, no. 6, pp. 1428–1437, 2012. View at Publisher · View at Google Scholar
  • Flavia R.S. Lima, Suzana Assad Kahn, Rossana C. Soletti, Deborah Biasoli, Tercia Alves, Anna Carolina C. da Fonseca, Celina Garcia, Luciana Romão, José Brito, Rosenilde Holanda-Afonso, Jane Faria, Helena Borges, and Vivaldo Moura-Neto, “Glioblastoma: Therapeutic challenges, what lies ahead,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1826, no. 2, pp. 338–349, 2012. View at Publisher · View at Google Scholar
  • Pierpaolo Peruzzi, and E. Antonio Chiocca, “Bringing the Endovascular Neurosurgeon into the Neuro-oncology Treatment Team,” World Neurosurgery, vol. 77, no. 1, pp. 59–61, 2012. View at Publisher · View at Google Scholar
  • Manmeet S. Ahluwalia, “Chemotherapy for Brain Tumors,” Schmidek and Sweet's Operative Neurosurgical Techniques, pp. 94–104, 2012. View at Publisher · View at Google Scholar
  • L. B. de Paula, F. L. Primo, D. R. Jardim, P. C. Morais, and A. C. Tedesco, “Development, characterization, and in vitro trials of chloroaluminum phthalocyanine-magnetic nanoemulsion to hyperthermia and photodynamic therapies on glioblastoma as a biological model,” Journal of Applied Physics, vol. 111, no. 7, pp. 07B307, 2012. View at Publisher · View at Google Scholar
  • Katsuyuki Shirai, Michael R. Siedow, and Arnab Chakravarti, “Antiangiogenic Therapy for Patients with Recurrent and Newly Diagnosed Malignant Gliomas,” Journal of Oncology, vol. 2012, pp. 1–12, 2012. View at Publisher · View at Google Scholar
  • Bo Zhang, Huafang Wang, Ziwei Liao, Yu Wang, Yue Hu, Jiarong Yang, Shun Shen, Jun Chen, Heng Mei, Wei Shi, Yu Hu, Zhiqing Pang, and Xinguo Jiang, “EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma,” Biomaterials, vol. 35, no. 13, pp. 4133–4145, 2014. View at Publisher · View at Google Scholar
  • Bin Wu, Longgui Sha, Yong Wang, Wei Xu, Yang Yu, Fang Feng, Caixing Sun, and Liang Xia, “Diagnostic and prognostic value of a disintegrin and metalloproteinase-17 in patients with gliomas,” Oncology Letters, vol. 8, no. 6, pp. 2616–2620, 2014. View at Publisher · View at Google Scholar
  • Jianpeng Chen, Yi Luan, Ruofei Yu, Zheng Zhang, Jinbiao Zhang, and Weibo Wang, “Transient receptor potential (TRP) channels, promising potential diagnostic and therapeutic tools for cancer,” Bioscience Trends, vol. 8, no. 1, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Wallys Garrido, Jose Dellis Rocha, Catherinne Jaramillo, Katia Fernandez, Carlos Oyarzun, Rody San Martin, and Claudia Quezada, “Chemoresistance in High-Grade Gliomas: Relevance of Adenosine Signalling in Stem-Like Cells of Glioblastoma Multiforme,” Current Drug Targets, vol. 15, no. 10, pp. 931–942, 2014. View at Publisher · View at Google Scholar
  • G. Parmaksiz, M. Czabanka, M. Vinci, and P. Vajkoczy, “Antiangiogenic Therapy Inhibits the Recruitment of Vascular Accessory Cells to the Perivascular Niche in Glioma Angiogenesis,” Journal of Vascular Research, vol. 51, no. 2, pp. 102–109, 2014. View at Publisher · View at Google Scholar
  • Richard C Curry, Saurabh Dahiya, Vyshak Alva Venur, Jeffrey J Raizer, and Manmeet S Ahluwalia, “Bevacizumab in high-grade gliomas: past, present, and future,” Expert Review of Anticancer Therapy, vol. 15, no. 4, pp. 387–397, 2015. View at Publisher · View at Google Scholar
  • Vyshak Alva Venur, David M. Peereboom, and Manmeet S. Ahluwalia, “Current medical treatment of glioblastoma,” Cancer Treatment and Research, vol. 163, pp. 103–115, 2015. View at Publisher · View at Google Scholar
  • Yuan-Yun Tseng, Yi-Chuan Kau, and Shih-Jung Liu, “Advanced interstitial chemotherapy for treating malignant glioma,” Expert Opinion on Drug Delivery, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • Peng Fu, Yun-Song He, Qin Huang, Tao Ding, Yong-Cun Cen, Hong-Yang Zhao, and Xiang Wei, “Bevacizumab treatment for newly diagnosed glioblastoma: Systematic review and meta-analysis of clinical trials,” Molecular and Clinical Oncology, vol. 4, no. 5, pp. 833–838, 2016. View at Publisher · View at Google Scholar
  • Manmeet S. Ahluwalia, Stephanie Bou-Anak, Monica E. Burgett, Nehaw Sarmey, Divya Khosla, Saurabh Dahiya, Robert J. Weil, Eunnyung Bae, Ping Huang, Mary McGraw, Lisa M. Grove, Mitchell A. Olman, Richard A. Prayson, John H. Suh, G. Yancey Gillespie, Jill Barnholtz-Sloan, Amy S. Nowacki, Gene H. Barnett, and Candece L. Gladson, “Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma,” Journal of Neuro-Oncology, 2016. View at Publisher · View at Google Scholar
  • Tatiana Byzova, Jeremy N. Rich, Candece L. Gladson, Justin D. Lathia, Deni S. Galileo, Elena Pugacheva, Amit Vasanji, Meizhang Li, Monica E. Burgett, Tom Mikkelsen, Shideng Bao, Michael Weller, Patrick Roth, Amy S. Nowacki, and Ping Huang, “Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells,” Oncotarget, vol. 7, no. 28, pp. 43852–43867, 2016. View at Publisher · View at Google Scholar
  • Jeremy Tetsuo Miyauchi, and Stella E. Tsirka, “Defining differential roles for microglia and infiltrating macrophages in the growth and neovascularization of glioma,” Translational Cancer Research, vol. 5, pp. S648–S651, 2016. View at Publisher · View at Google Scholar
  • Chen-Hsing Su, Shou-Cheng Liu, Shih-Jung Liu, Yuan-Yun Tseng, Shun-Tai Yang, Yin-Chen Huang, Wei-Hwa Lee, and Yi-Chuan Wang, “Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes,” Oncotarget, vol. 7, no. 37, pp. 59902–59916, 2016. View at Publisher · View at Google Scholar
  • Hanmei Li, Yuna Tong, Lan Bai, Lei Ye, Lei Zhong, Xingmei Duan, and Yuxuan Zhu, “Lactoferrin Functionalized PEG-PLGA Nanoparticles of Shikonin for Brain Targeting Therapy of Glioma,” International Journal of Biological Macromolecules, 2017. View at Publisher · View at Google Scholar
  • Emilio Ciusani, Moris Cadei, Gaetano Finocchiaro, Augusto Pessina, Eugenio Parati, Roberto Pallini, Giulio Alessandri, Marco Paolo Schiariti, Francesco Restelli, Paolo Ferroli, Anna Benetti, Angiola Berenzi, Anna Ferri, and Valentina Ceserani, “Fibronectin-adherent peripheral blood derived mononuclear cells as Paclitaxel carriers for glioblastoma treatment: An in vitro study,” Cytotherapy, 2017. View at Publisher · View at Google Scholar
  • Tao-Chieh Yang, Yi-Chuan Wang, Tzu-Min Chang, Yi-Chuan Kau, Yuan-Yun Tseng, Wei-Hwa Lee, and Shih-Jung Liu, “Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes,” International Journal of Nanomedicine, vol. 12, pp. 1265–1276, 2017. View at Publisher · View at Google Scholar
  • Shou-Bo Yang, Tao Jiang, Wen-Bin Li, Kai-Di Gao, and Shu-Jun Cheng, “Bevacizumab combined with chemotherapy for glioblastoma: A meta-analysis of randomized controlled trials,” Oncotarget, vol. 8, no. 34, pp. 57337–57344, 2017. View at Publisher · View at Google Scholar